ADHD Prescription Medications and Their Effect on Athletic Performance: A Systematic Review and Meta-analysis

[1] Han DH(2019)Attention-deficit/hyperactivity disorder in elite athletes: a narrative review Br J Sports Med 53 741-745

[2] McDuff D(2014)The potential for misuse and abuse of medications in ADHD: a review Postgrad Med 126 64-81

[3] Thompson D(2009)The misuse and diversion of prescribed ADHD medications by college students J Atten Disord 13 144-153

[4] Hitchcock ME(2016)The role of dopamine and its dysfunction as a consequence of oxidative stress Oxid Med Cell Longev 2016 9730467-270

[5] Reardon CL(2018)The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities Neurosci Biobehav Rev 87 255-256

[6] Hainline B(2019)Considerations in the care of athletes with attention deficit hyperactivity disorder Clin J Sport Med 29 245-313

[7] Clemow DB(2019)Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects Drug Metab Rev 51 293-711

[8] Walker DJ(2002)Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 699-373

[9] Rabiner DL(2010)Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder Curr Psychiatry Rep 12 366-107

[10] Anastopoulos AD(1991)The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task Behav Neural Biol 56 101-247

[1] Han DH(2019)Attention-deficit/hyperactivity disorder in elite athletes: a narrative review Br J Sports Med 53 741-745

[2] McDuff D(2014)The potential for misuse and abuse of medications in ADHD: a review Postgrad Med 126 64-81

[3] Thompson D(2009)The misuse and diversion of prescribed ADHD medications by college students J Atten Disord 13 144-153

[4] Hitchcock ME(2016)The role of dopamine and its dysfunction as a consequence of oxidative stress Oxid Med Cell Longev 2016 9730467-270

[5] Reardon CL(2018)The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities Neurosci Biobehav Rev 87 255-256

[6] Hainline B(2019)Considerations in the care of athletes with attention deficit hyperactivity disorder Clin J Sport Med 29 245-313

[7] Clemow DB(2019)Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects Drug Metab Rev 51 293-711

[8] Walker DJ(2002)Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 699-373

[9] Rabiner DL(2010)Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder Curr Psychiatry Rep 12 366-107

[10] Anastopoulos AD(1991)The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task Behav Neural Biol 56 101-247